Compare SUPN & OLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUPN | OLN |
|---|---|---|
| Founded | 2005 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.0B |
| IPO Year | 2010 | 1994 |
| Metric | SUPN | OLN |
|---|---|---|
| Price | $45.61 | $24.52 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 13 |
| Target Price | ★ $61.60 | $25.23 |
| AVG Volume (30 Days) | 492.7K | ★ 1.8M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.92% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $392,755,000.00 | ★ $6,780,800,000.00 |
| Revenue This Year | $22.70 | $2.57 |
| Revenue Next Year | $19.14 | $3.51 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 3.68 |
| 52 Week Low | $31.16 | $18.08 |
| 52 Week High | $59.68 | $30.46 |
| Indicator | SUPN | OLN |
|---|---|---|
| Relative Strength Index (RSI) | 41.88 | 36.48 |
| Support Level | $43.67 | $22.82 |
| Resistance Level | $46.89 | $24.83 |
| Average True Range (ATR) | 1.46 | 0.88 |
| MACD | -0.17 | -0.19 |
| Stochastic Oscillator | 34.48 | 18.29 |
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.